Literature DB >> 21821866

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.

Serena Guiducci1, Mirko Manetti, Eloisa Romano, Benedetta Mazzanti, Claudia Ceccarelli, Simone Dal Pozzo, Anna Franca Milia, Silvia Bellando-Randone, Ginevra Fiori, Maria Letizia Conforti, Riccardo Saccardi, Lidia Ibba-Manneschi, Marco Matucci-Cerinic.   

Abstract

OBJECTIVE: To characterise bone marrow-derived mesenchymal stem cells (MSCs) from patients with systemic sclerosis (SSc) for the expression of factors implicated in MSC recruitment at sites of injury, angiogenesis and fibrosis. The study also analysed whether the production/release of bioactive mediators by MSCs were affected by stimulation with cytokines found upregulated in SSc serum and tissues, and whether MSCs could modulate dermal microvascular endothelial cell (MVEC) angiogenesis.
METHODS: MSCs obtained from five patients with early severe diffuse SSc (SSc-MSCs) and five healthy donors (H-MSCs) were stimulated with vascular endothelial growth factor (VEGF), transforming growth factor β (TGFβ) or stromal cell-derived factor-1 (SDF-1). Transcript and protein levels of SDF-1 and its receptor CXCR4, VEGF, TGFβ(1) and receptors TβRI and TβRII were evaluated by quantitative real-time PCR, western blotting and confocal microscopy. VEGF, SDF-1 and TGFβ(1) secretion in culture supernatant was measured by ELISA. MVEC capillary morphogenesis was performed on Matrigel with the addition of MSC-conditioned medium.
RESULTS: In SSc-MSCs the basal expression of proangiogenic SDF-1/CXCR4 and VEGF was significantly increased compared with H-MSCs. SSc-MSCs constitutively released higher levels of SDF-1 and VEGF. SDF-1/CXCR4 were upregulated after VEGF stimulation and CXCR4 redistributed from the cytoplasm to the cell surface. VEGF was increased by SDF-1 challenge. VEGF, TGFβ and SDF-1 stimulation upregulated TGFβ(1), TβRI and TβRII in SSc-MSCs. TβRII redistributed from the cytoplasm to focal adhesion contacts. SSc-MSC-conditioned medium showed a greater proangiogenic effect on MVECs than H-MSCs. Experiments with blocking antibodies showed that MSC-derived cytokines were responsible for this potent proangiogenic effect.
CONCLUSION: SSc-MSCs constitutively overexpress and release bioactive mediators/proangiogenic factors and potentiate dermal MVEC angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821866     DOI: 10.1136/ard.2011.150607

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

Review 1.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors:  Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

2.  MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis.

Authors:  Zhongyu Xie; Peng Wang; Jinteng Li; Yuxi Li; Shan Wang; Xiaohua Wu; Suhe Sun; Shuizhong Cen; Hongjun Su; Wen Deng; Zhenhua Liu; Yi Ouyang; Yanfeng Wu; Huiyong Shen
Journal:  J Mol Med (Berl)       Date:  2016-12-05       Impact factor: 4.599

3.  Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis.

Authors:  Chiara Capelli; Eleonora Zaccara; Paola Cipriani; Paola Di Benedetto; Wanda Maglione; Romina Andracco; Gabriele Di Luca; Francesca Pignataro; Roberto Giacomelli; Martino Introna; Claudio Vitali; Nicoletta Del Papa
Journal:  Cell Transplant       Date:  2017-01-31       Impact factor: 4.064

4.  Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.

Authors:  Xiaoyun Si; Ximing Liu; Jingjing Li; Xiaoyan Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro.

Authors:  Arsalan Shabbir; Audrey Cox; Luis Rodriguez-Menocal; Marcela Salgado; Evangelos Van Badiavas
Journal:  Stem Cells Dev       Date:  2015-05-20       Impact factor: 3.272

Review 6.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

7.  Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.

Authors:  Hendrik Gremmels; Martin Teraa; Paul Ha Quax; Krista den Ouden; Joost O Fledderus; Marianne C Verhaar
Journal:  Mol Ther       Date:  2014-09-01       Impact factor: 11.454

8.  Systemic neutralization of TGF-β attenuates osteoarthritis.

Authors:  Liang Xie; Francis Tintani; Xiao Wang; Fengfeng Li; Gehua Zhen; Tao Qiu; Mei Wan; Janet Crane; Qianming Chen; Xu Cao
Journal:  Ann N Y Acad Sci       Date:  2016-02-02       Impact factor: 5.691

9.  Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients.

Authors:  Valérie Vanneaux; Dominique Farge-Bancel; Séverine Lecourt; Julie Baraut; Audrey Cras; Francette Jean-Louis; Cécilia Brun; Franck Verrecchia; Jérôme Larghero; Laurence Michel
Journal:  BMJ Open       Date:  2013-01-07       Impact factor: 2.692

10.  Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.

Authors:  Ralf Hass; Anna Otte
Journal:  Cell Commun Signal       Date:  2012-09-03       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.